Ana Luiza Fontes de Azevedo Costa Thiago Gonçalves Dos Santos Martins Francisco Javier Solano Moncada Mário Martins dos Santos Motta
10.1590/s1679-45082014rc2708
Einstein (Sao Paulo)
2014 Jan-Mar;12(1):106-8.
CC BY
https://pubmed.ncbi.nlm.nih.gov/24728255/
Intravitreal Injections / methods Retinal Hemorrhage / drug therapy Retinal Hemorrhage / etiology Toxoplasmosis, Congenital / complications Toxoplasmosis, Congenital / drug therapy
Intravitreal Injections / methods Retinal Hemorrhage / drug therapy Retinal Hemorrhage / etiology Toxoplasmosis, Congenital / complications Toxoplasmosis, Congenital / drug therapy Case Reports Adolescent Angiogenesis Inhibitors / administration & dosage Antibodies, Monoclonal, Humanized / administration & dosage Bevacizumab Contrast Media Female Fluorocarbons Humans Time Factors Treatment Outcome Visual Acuity Angiogenesis Inhibitors Antibodies, Monoclonal, Humanized Contrast Media Fluorocarbons Bevacizumab perflutren
PMC4898248
24728255
Submacular hemorrhage secondary to congenital toxoplasmosis
2014